In colon cancer, in which IL-6R was correlated with the tumor size of the patients, a role of IL-6R in colorectal cancer progression was suggested and its possible roles as a biomarker could be useful in the follow-up disease and as potential targets for the therapy (Waldner et al., 2012; Turano et al., 2021). This evidence concerns the gene IL6R and colorectal cancer.